Health-economic evaluation of an AI-powered decision support system for anemia management in in-center hemodialysis patients.

Journal: BMC nephrology
Published Date: Aug 28, 2025

Abstract

BACKGROUND: The Anemia Control Model (ACM) is a decision support system powered by an artificial intelligence core designed to assist nephrologists in managing anemia therapy for in-center hemodialysis (HD) patients. This study aims to evaluate the cost-effectiveness of the ACM compared to standard of care in Germany, defined as the absence of ACM and a hemoglobin (Hb) target achievement rate of less than 70% among in-center HD patients, based on results from matched observational studies.

Authors

  • Afschin Gandjour
    Frankfurt School of Finance & Management, Frankfurt, Germany. a.gandjour@fs.de.
  • Christian Apel
    Market Access, Health Economics & Political Affairs, Fresenius Medical Care Deutschland GmbH, Bad Homburg, Germany.
  • Dana Kendzia
    Market Access, Health Economics & Political Affairs, Fresenius Medical Care Deutschland GmbH, Bad Homburg, Germany.
  • Luca Neri
    Fresenius Medical Care, Bad Homburg, Germany.
  • Francesco Bellocchio
    Fresenius Medical Care Italia, Vaiano Cremasco, Cremona, Italy.
  • Len Usvyat
    Fresenius Medical Care, Global Medical Office, 920 Winter Street, Waltham, MA, 02451, USA.
  • John Larkin
    Fresenius Medical Care, Global Medical Office, 920 Winter Street, Waltham, MA, 02451, USA.
  • Jovana Petrovic Vorkapic
    Market Access, Health Economics & Political Affairs, Fresenius Medical Care Deutschland GmbH, Bad Homburg, Germany.

Keywords

External Resources

Popular Topics
Recent Journals